AML - Emerging Treatment Strategies
Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.
Date: July 19, 2012
Time: 1:00 p.m. - 2:00 p.m. ET
Location: Telephone/Web
Target Audience: Oncology nurses and social workers involved in the treatment of patients with AML
Download: Program Slides | Transcript
Listen: Presentation | Q&A Session | Extended Q&A
Access: Virtual Lecture
Activity Purpose
To educate oncology nurses and social workers about treatment options for acute myeloid leukemia (AML).
Educational Objectives
At the conclusion of this program, participants should be able to:
- List three signs or symptoms of AML
- List two blood and marrow tests used to diagnose AML
- Identify two current and two emerging treatment options
- Describe two treatment side effects and strategies for side effect management
- Explain the role of clinical trials in the continuing improvement of AML treatment outcomes
- Share two information and support resources for patients and caregivers
Speaker
Wendy Stock, MD
Professor of Medicine, Section of Hematology/Oncology
Director, Leukemia Program
The University of Chicago Medicine
Chicago, IL
Sponsors and Supporters
This program was sponsored by The Leukemia & Lymphoma Society.
